The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Body Weight Changes Associated With Psychopharmacology
Abstract
OBJECTIVE: The authors discuss changes in body weight associated with various psychopharmaceuticals. METHODS: A large number of articles and books about drug-induced changes in body weight, selected on the basis of various literature searches and the authors' clinical experiences with psychopharmaceuticals, were reviewed. RESULTS: Many psychotropic drugs with antipsychotic, mood stabilizing, and antidepressant properties are associated with weight gain. Others, such as fluoxetine, isocarboxazid, nefazadone, topiramate, and psychostimulants, may cause weight loss. The antipsychotic drugs chlorpromazine, clozapine, and olanzapine are often associated with weight gain. Among antidepressants, amitriptyline and mirtazapine are known to cause weight gain. However, reductions are sometimes observed, and each antidepressant has its own unique weight-effect profile. Mood stabilizers, especially valproate-related products, are also associated with weight gain. CONCLUSIONS: Careful monitoring and consideration of alternative therapies are essential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antipsychotic-induced weight gain: a comprehensive research synthesis
Allison, D. B., Mentore, J. L., Heo, M., Chandler, L. P., Cappelleri, J. C., Infante, M. C., & Weiden, P. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1686 · Cited by 2,382
Research works printed but not linked: 56
- Payne P, Dugdale A: Mechanisms for the control of body weight. Lancet 12:583-585, 1977 · DOI
- Aquila R, Emanuel M: Weight gain and antipsychotic medication. Journal of Clinical Psychiatry 60:336-337, 1999 · DOI
- Berken G, Weinstein D, Stern W: Weight gain: a side effect of tricyclic antidepressants. Journal of Affective Disorders 7:133-138, 1984 · DOI · Paper page
- Umbricht D, Kane J: Medical complications of new antipsychotic drugs. Schizophrenia Bulletin 22:475-483, 1996 · DOI
- Brady K: Weight gain associated with psychotropic drugs. Southern Medical Journal 82:611-617, 1989 · DOI
- Holden J, Holden U: Weight changes with schizophrenic psychosis and psychotropic drug therapy. Psychosomatics 9:551-561, 1970 · DOI
- Fallon I, Watt D, Sheperd M: Pimozide and fluphenazine decanoate in continuation therapy. Psychological Medicine 8:59-70, 1979 · DOI · Paper page
- Heikinen H, Outakoski J, Merilainen V, et al: Molindone and weight loss. Journal of Clinical Psychiatry 54:160-161, 1993
- Gardos G, Cole J: Weight reduction in schizophrenics by molindone. American Journal of Psychiatry 134:302-304, 1977 · DOI
- Lamberti S, Terrance B, Schwarzkopf S: Weight gain among schizophrenic patients treated with clozapine. American Journal of Psychiatry 149:689-690, 1992 · doi:10.1176/ajp.149.5.689
- Umbricht D, Pollack S, Kane J: Clozapine and weight gain. Journal of Clinical Psychiatry 55:157-160, 1994
- Bai Y, Lin C, Chen J, et al: Weight gain among patients on clozapine. Psychiatric Services 50:704-705, 1999 · DOI
- Meltzer H: Adverse effects of the atypical antipsychotics. Journal of Clinical Psychiatry 59:17-22, 1998
- Melkersson U, Hulting A, Bismar K: Different influences of classical antipsychotics and clozapine on glucose-insulin homeostasis in patients with schizophrenia or related psychoses. Journal of Clinical Psychiatry 60:783-791, 1999 · DOI
- Wetterling T, Mubigbrodt H: Weight gain: side effect of atypical neuroleptics. Journal of Clinical Psychopharmacology 19:316-321, 1999 · DOI
- Gupta S, Droney T, Al-Samarrai S, et al: Olanzapine: weight gain and therapeutic efficacy. Journal of Clinical Psychopharmacology 19:273-274, 1999 · doi:10.1097/00004714-199906000-00014
- Beasley C: The safety of olanzapine. Journal of Clinical Psychiatry 15:19-21, 1997
- Tran P, Hamilton S, Kuntz A, et al: Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. Journal of Clinical Psychopharmacology 17:407-418, 1997 · DOI · Paper page
- Song F: Risperidone in the treatment of schizophrenia: a meta-analysis of randomized controlled trials. Journal of Clinical Psychopharmacology 11:65-71, 1997 · DOI
- Ganguli R, Brar J, Ayrton Z: Weight gain over 4 months in schizophrenia patients: a comparison of olanzapine and risperidone. Schizophrenia Research 49:261-267, 2001 · DOI
- Peuskens J: Risperidone in the treatment of patients with chronic schizophrenia: a multinational, multicentered, double-blind, parallel-group study versus haloperidol. British Journal of Psychiatry 166:712-733, 1995 · DOI · Paper page
- Crockford D, Fisher G, Barker P: Risperidone, weight gain, and bulimia nervosa. Canadian Journal of Psychiatry 4:326-327, 1997 · DOI
- Wirshing D, Wirshing W, Kysar L, et al: Novel antipsychotics: weight gain liabilities. Journal of Clinical Psychiatry 60:358-363, 1999 · DOI · Paper page
- Borison R, Arvanitis L, Miller B, et al: ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. Journal of Clinical Psychopharmacology 16:158-169, 1996 · DOI · Paper page
- Barnes T, McPhillips M: Critical analysis and comparison of the side-effect and safety profiles of the new antipsychotics. British Journal of Psychiatry 174(38S):34-43, 1999 · DOI
- Rosenfeld W, Shaefer P, Pace K: Weight loss patterns with topiramate therapy. Epilepsia 38:60-63, 1997 · doi:10.1111/j.1528-1157.1997.tb04516.x
- Gordon A, Price L: Mood stabilization and weight loss with topiramate. American Journal of Psychiatry 156:968-969, 1999 · DOI
- Vendsborg P, Bech P, Rafaelsen O: Lithium treatment and weight gain. Acta Psychiatrica Scandinavica 53:139-147, 1976 · DOI
- Peslow E, Dunner D, Fieve R, et al: Lithium carbonate and weight gain. Journal of Affective Disorders 2:303-310, 1980 · DOI
- Vendsborg P, Rafaelsen O: Lithium in man: effect on glucose tolerance and serum electrolytes. Acta Psychiatrica Scandinavica 43:601-610, 1973 · doi:10.1111/j.1600-0447.1973.tb04451.x
- Shopsin B, Stern S, Gershon S: Altered carbohydrate metabolism during treatment with lithium carbonate. Archives of General Psychiatry 28:566-571, 1972 · DOI
- Vendsborg P, Prytz S: Glucose tolerance and serum lipids in man after long-term lithium administration. Acta Psychiatrica Scandinavica 53:64-69, 1976 · doi:10.1111/j.1600-0447.1976.tb00059.x
- Sussman N, Ginsberg D: Effect of psychotropic drugs on weight. Psychiatric Annals 29:580-594, 1999 · doi:10.3928/0048-5713-19991001-08
- Davis R, Peters D, McTavish D: Valproic acid: a reappraisal of its pharmacological properties and clinical efficacy in epilepsy. Drugs 47:332-342, 1994 · doi:10.2165/00003495-199447020-00008
- Dinesen H, Lennart G, Andersen T, et al: Weight gain during treatment with valproate. Acta Neurologica Scandinavica 70:65-69, 1984 · doi:10.1111/j.1600-0404.1984.tb00804.x
- Verrotti A, Basciani F, Morresi S, et al: Serum leptin changes in epileptic patients who gain weight after therapy with valproic acid. Neurology 53:230-232, 1999 · doi:10.1212/wnl.53.1.230
- Joffe R, Post R, Uhde T: Effect of carbamazepine on body weight in affectively ill patients. Journal of Clinical Psychiatry 47:313-314, 1986
- Lampl Y, Eshel Y, Rapaport A, et al: Weight gain, increased appetite, and excessive food intake induced by carbamazepine. Clinical Neuropharmacology 14:251-255, 1991 · DOI
- Meldrum B: Update on the mechanism of action of antiepileptic drugs. Epilepsia 37(suppl 6):4-11, 1996 · DOI · Paper page
- Betts T, Goodwin G, Withers R, et al: Human safety of lamotrigine. Epilepsia 32 (suppl 2):17-21, 1991 · DOI
- Hinze-Selch D, Schuld A, Kraus T, et al: Effects of antidepressants on weight and on the plasma levels of leptin, TNF-a, and soluble TNF receptors. Neuropsychopharmacology 23:13-19, 2000 · DOI
- Yergani V, Rohl R, Aleem A, et al: Carbohydrate craving and increased appetite associated with antidepressant therapy. Canadian Journal of Psychiatry 33:606-610, 1988 · doi:10.1177/070674378803300706
- Trivedi M, Rush A: A review of randomized controlled medication trials in major depression. Biological Psychiatry 31:188-189, 1992 · doi:10.1016/0006-3223(92)90650-o
- Fernstrom M, Krowinski R, Kupfer D: Chronic imipramine treatment and weight gain. Psychiatry Research 17:269-273, 1986 · DOI
- Garland E, Remick R, Zis A: Weight gain with antidepressants and lithium. Journal of Clinical Psychopharmacology 8:323-330, 1988 · DOI
- Paradis C, Stack J, George C, et al: Nortriptyline and weight change in depressed patients over 60. Journal of Clinical Psychopharmacology 12:246-250, 1992 · doi:10.1097/00004714-199208000-00006
- Gantu T, Korek J: Monoamine oxidase inhibitors and weight gain. Clinical Pharmacology 22:755-759, 1988 · DOI
- Delgano P, Charney D, Price L, et al: Serotonin function and the mechanism of antidepressant action. Archives of General Psychiatry 47:411-418, 1990 · DOI · Paper page
- Rosalinda T: Change in weight during a one-year trial with fluoxetine. Journal of Clinical Psychiatry 53:259-267, 1992
- Tollefson G, Holman S, Saylor M, et al: Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features. Journal of Clinical Psychiatry 55:50-59, 1994
- Beasley C, Sayler M, Bosomworth J, et al: High dose fluoxetine: efficacy and activating-sedating effects. Journal of Clinical Psychiatry 303:685-692, 1991
- Bouwer C, Harvey B: Phasic craving for carbohydrate observed with citalopram. International Journal of Clinical Psychopharmacology 11:273-278, 1996 · DOI
- Kupfer D, Coble P, Rubinstein D: Changes in weight during treatment for depression. Psychosomatic Medicine 41:535-544, 1979 · DOI
- Gorman J: Mirtazapine: clinical overview. Journal of Clinical Psychiatry 60:9-12, 1999
- Robinson D, Roberts D, Smith J, et al: The safety profile of nefazodone. Journal of Clinical Psychiatry 57:31-37, 1996
- Evans S, Foltin R, Fischman M: Food "craving" and the acute effect of alprazolam on food intake in women with premenstrual dysphoric disorder. Appetite 32:331-349, 1999 · DOI
Cited by
DE HERT, M., CORRELL, C. U., BOBES, J., CETKOVICH‐BAKMAS, M., COHEN, D., ASAI, I., DETRAUX, J., GAUTAM, S., MÖLLER, H., NDETEI, D. M., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00014.x · Cited by 2,488
Blaine, B. (2008) · Journal of Health Psychology · doi:10.1177/1359105308095977 · Cited by 372
A Longitudinal Evaluation of Adolescent Depression and Adult Obesity
Richardson, L. P., Davis, R., Poulton, R., McCauley, E., Moffitt, T. E., Caspi, A., & Connell, F. (2003) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.157.8.739 · Cited by 317
Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review
Wang, S.-M., Han, C., Bahk, W.-M., Lee, S.-J., Patkar, A. A., Masand, P. S., & Pae, C.-U. (2018) · Chonnam Medical Journal · doi:10.4068/cmj.2018.54.2.101 · Cited by 299
Inequitable access for mentally ill patients to some medically necessary procedures
Kisely, S., Smith, M., Lawrence, D., Cox, M., Campbell, L. A., & Maaten, S. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.060482 · Cited by 185
Metadata
- Authors
- Vanina, Y., Podolskaya, A., Sedky, K., Shahab, H., Siddiqui, A., Munshi, F., & Lippmann, S.
- Venue
- Psychiatric Services
- Published
- 2002-07
- Volume
- 53
- Issue
- 7
- Pages
- 842-847
- ISSN
- 0022-1597 (ISSN-L)
- 1075-2730
- 1557-9700
- OpenAlex
- W2159325340
- Cited by
- 162
- References
- 1
- FWCI
- 5.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.